Novel Coronavirus (SARS-CoV-2/COVID-19)
The Centers for Disease Control and Prevention today announced a major adjustment of its federal masking guidance pertaining to the COVID-19 public health emergency, including changes to the metrics that communities are urged to use when determining whether to require face coverings in indoor…
AHA Health Systems Leadership Retreat Keynote: A Tapestry of Voices with Anna Deavere Smith. Anna Deavere Smith, Actress, Playwright, Professor, and McArthur Foundation Genius Fellow, shares a range of health care perspectives from those she has interviewed over the years.
The Health Resources and Services Administration will distribute $560 million in Provider Relief Fund “Phase 4” payments to providers who experienced revenue losses and expenses related to the COVID-19 pandemic based on changes in operating revenues and expenses from July 1, 2020, to March 31, 2021…
The Food and Drug Administration yesterday listed all over-the-counter COVID-19 diagnostic tests authorized for home use, including links to home use instructions for each test.
President Biden released a notice extending the national emergency declaration for the COVID-19 pandemic beyond March 1. The notice will be published in tomorrow’s Federal Register. It does not indicate an end date for the emergency declaration.
The Centers for Medicare & Medicaid Services (CMS) Jan. 12 released a proposed rule for the Medicare Advantage program, which includes a request for information (RFI) on prior authorization for hospital transfers to post-acute care settings during a public health emergency. The AHA has…
The AHA released the latest edition of its COVID-19 Snapshot underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
Baptist Health in Jacksonville, Florida, reflects on lessons learned and best practices moving forward. We know that our field will continue to be challenged by COVID-19, but this pandemic has taught us a valuable lesson: The future is not going to wait for us, and instead we have to be ready to…
During the omicron wave, the Pfizer or Moderna COVID-19 vaccine was 87% effective at preventing emergency and urgent care visits and 95% effective at preventing hospitalizations in adults who received a third dose in the prior two months, according to a study released by the Centers for Disease…
The Food and Drug Administration today authorized emergency use of the monoclonal antibody bebtelovimab to treat COVID-19 in outpatients at risk of progressing to severe disease or hospitalization.